Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1073 of 6351
-
Could calming Moms-to-Be boost baby brain health?
Prevention CompletedThe goal of this clinical trial is to determine whether antenatal maternal stress management using relaxation techniques improves breastfeeding effectiveness and neonatal neurodevelopmental outcomes. It is hypothesized that reducing maternal stress during pregnancy will enhance t…
Sponsor: National and Kapodistrian University of Athens • Aim: Prevention
Last updated Aug 12, 2026 00:00 UTC
-
Which palliative care approach boosts quality of life in advanced lung cancer?
Symptom relief CompletedThis research study is evaluating ways to provide palliative care to patients who have recently been diagnosed with lung cancer
Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated Aug 05, 2026 00:00 UTC
-
Could a simple education program stop the cycle of fractures in the elderly?
Prevention CompletedThis is a study on the effects of education on secondary fracture prevention in primary health care centers (PHCC) and referral from hospitals to these PHCC of patients with recent fragility fractures. The design is Cluster-randomized controlled study with two arms. 40 primary h…
Sponsor: Helena Salminen • Aim: Prevention
Last updated Aug 27, 2026 00:00 UTC
-
Vaccine-Immunotherapy combo takes aim at Hard-to-Treat ovarian cancer
Disease control OngoingThis phase II trial studies how well modified vaccinia virus ankara vaccine expressing p53 (p53MVA) and pembrolizumab work in treating patients with ovarian, primary peritoneal, or fallopian tube cancer that has come back (recurrent). Vaccines made from a gene-modified virus may …
Phase 2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Shorter radiation may be just as good for prostate cancer
Disease control OngoingThis randomized phase III trial studies how well stereotactic body radiation therapy works compared to intensity-modulated radiation therapy in treating patients with stage IIA-B prostate cancer. Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors. Ste…
Phase 3 • Sponsor: NRG Oncology • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
New cocktail aims to stall pancreatic cancer after chemo
Disease control CompletedThe main purpose of this study is to look at the effectiveness, safety, and anti-tumor activity (preventing growth of the tumor) of the drugs Niraparib with either Ipilimumab or Nivolumab on patients and their pancreatic cancer.
Phase 1/2 • Sponsor: University of Pennsylvania • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
Heart device aims to cut stroke risk in PFO patients
Disease control OngoingThe purpose of this single arm, multi-center study is to confirm the safety and effectiveness of the AMPLATZER™ PFO Occluder in the post Approval Setting.
Sponsor: Abbott Medical Devices • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New combo shows promise in Tough-to-Treat breast cancer
Disease control CompletedThis research study is studying a drug called Carboplatin with or without another study drug, Nivolumab as a possible treatment for triple-negative breast cancer that has spread to other parts of the body. The interventions involved in this study are: * Carboplatin * Nivolumab
Phase 2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Sep 10, 2026 01:00 UTC
-
Throat cancer showdown: radiation vs. surgery in HPV patients
Disease control OngoingThe goal of this randomized treatment de-escalation study is to formally compare outcomes in HPV related oropharyngeal cancer tumors treated with a primary radiotherapy versus a primary surgical approach, to provide a high level of evidence to guide the selection of treatment opt…
Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New psoriasis drug shows promise in Head-to-Head trial
Disease control CompletedThis is a study to compare the efficacy of bimekizumab versus adalimumab in the treatment of subjects with moderate to severe chronic plaque psoriasis (PSO).
Phase 3 • Sponsor: UCB Biopharma SRL • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Proton beams vs X-Rays: which is better for liver cancer?
Disease control OngoingThis phase III trial studies how well radiation therapy with protons works compared with photons in treating patients with liver cancer. Radiation therapy, such as photon therapy, uses high energy x-rays to send the radiation inside the body to the tumor while proton therapy uses…
Phase 3 • Sponsor: NRG Oncology • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Can a wearable sensor help young people with type 1 diabetes tame blood sugar swings?
Disease control CompletedAdolescents and young adults with T1D and poor glycemic control (age 14-\< 25 years, T1D duration \>12 months, HbA1c 7.5-\<11.0%, using an insulin pump or MDI)) will be randomly assigned to either CGM or BGM. Sample size will be 150. The primary outcome assessment will be HbA1c a…
Phase 3 • Sponsor: Jaeb Center for Health Research • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
Can cord blood t cells be trained to stop viral infections after transplant?
Disease control OngoingThis Phase I-II dose-finding trial to determine the optimal dose of intravenous (IV) injection dose of donor-derived cytotoxic T lymphocytes (CTLs) specific for CMV, EBV, BKV and Adenovirus. A maximum of 36 patients will be treated in up to 18 cohorts each of size 2, with the fir…
Phase 1/2 • Sponsor: Catherine Bollard • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
New drug combo takes on deadly breast cancer in small trial
Disease control CompletedThis research study is studying Ruxolitinib as possible treatment for Inflammatory Breast Cancer (IBC). The Following drugs will be use in combination with Ruxolinitinib. * Paclitaxel (also called Taxol) * Doxorubicin also called Adriamycin * Cyclophosphamide, also called Cytox…
Phase 2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Can a single shot stop clots? a new drug puts the idea to the test
Disease control CompletedThe goal of this study is to find out if a drug called selatogrel (ACT-246475) can prevent platelets from binding together when administered by an injection under the skin in the thigh or in the belly. Another goal is to know how fast and for how long selatogrel (ACT-246475) work…
Phase 2 • Sponsor: Viatris Innovation GmbH • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC
-
Brain radiation showdown: proton vs. photon – which saves your mind?
Disease control OngoingThis randomized phase II clinical trial studies the side effects and how well proton beam or intensity-modulated radiation therapy works in preserving brain function in patients with IDH mutant grade II or III glioma. Proton beam radiation therapy uses tiny charged particles to d…
Phase 2 • Sponsor: NRG Oncology • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
New drug combo shows promise for tough sarcoma cases
Disease control OngoingThe purpose of this study is to test any good and bad effects of the combination therapy of epacadostat and pembrolizumab and to determine how well the combination therapy works in the treatment of patients with sarcoma.
Phase 2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Could a common antibiotic save diabetic feet from amputation?
Disease control CompletedThe purpose of this research study is to determine if rifampin, an antibiotic (a medicine that treats infections), is effective in treating osteomyelitis (infection of the bone) of the foot in diabetic patients. Despite use of powerful antibiotics prescribed over a long period of…
Phase 4 • Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
Could your own belly fat fix ED after prostate cancer surgery?
Disease control CompletedThe goal of this study was to investigate if adipose derived regenerative cells can be used as a treatment for erectile dysfunction following radical prostatectomy. 70 participants were enrolled in the study and was performed as a double- blinded study. 35 participants in the ac…
Phase 2 • Sponsor: Odense University Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Electric jolt workouts: a new hope for paralyzed limbs?
Disease control Recruiting nowThe purpose of this research study is to evaluate the effectiveness of an exercise training intervention (24-36 sessions) to improve muscle strength and endurance in the lower limbs of individuals with paralysis. Specifically, surface electrical stimulation or previously implante…
Sponsor: Louis Stokes VA Medical Center • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC